Challenge TB | Lead Partner: KNCV | Country Director: Dr. Bassey Nsa

Our Activities

KNCV-led, USAID-funded TB REACH Nigeria / Challenge TB project (CTB) in Nigeria was a 5-year program that concentrates its activities in 12 priority states and helped to strengthen national-level systems. The project aligned with the National TB Strategic Plan 2014-2020 to ensure state specific interventions with the aim of improving universal access to TB diagnosis and treatment through strategic expansion of services.

Nigeria is a high TB burden country where underdiagnosis is a major challenge, meaning far too many patients do not receive proper treatment. This is one of the reasons why the CTB focused on expanding diagnostic and treatment services, through community-based approaches. Examples of these community-based approaches are the engagement with Patent Medicine Vendors (PMVs) and community volunteer, Contact Investigators.

The GeneXpert MTB/RIF test from Cepheid HBDC, endorsed by the World Health Organization (WHO) for roll-out in 2010, has tremendous potential for improving TB diagnostic capacity and, as such, TB control in high-burden countries. KNCV was appointed as authorized service provider (ASP) for GeneXpert in the year 2014.

The KNCV-led TB REACH project, “Scaling up Innovative Delivery of TB Care to Nomadic populations in northeastern Nigeria”, funded by the Stop TB Partnership, was coordinated on the ground by two community-based organizations (CBOs) active in three states
in northeastern Nigeria. In 2019, nearly 3,000 confirmed TB cases were diagnosed and put on appropriate treatment as a result of this project.

The PMVs are typically the first point of care for the majority of Nigerians suffering from respiratory problems. In 2017, 2,367 PMVs were engaged and trained by the CTB Nigeria team to identify potential TB cases and referred for diagnosis and treatment. A total of 18,979 presumptive patients were referred by PMVs leading to a diagnosis of 1,568 TB positive patients. In the case of Contact Investigators, more than 1000 people have been diagnosed and put on treatment following home visits to exiting TB patients. The 338 Contact Investigators test the family members of existing TB patients and those with a positive diagnosis are immediately placed on treatment. To avoid and prevent further infection transmission with affected families, preventative medication is provided to children under the age of five who live in households with TB patients.

Our Office

KNCV Tuberculosis Foundation in Nigeria

Block B 4th Floor

Plot 564-565, Independence Avenue

Central Business District

Abuja, Nigeria